These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiac surgery in a patient with retroperitoneal fibrosis and heart valvulopathy, both due to pergolide medication for Parkinson's disease. Apostolakis EE; Baikoussis NG; Tselikos D; Koniari I; Prokakis C; Fokaeas E; Karanikolas M J Cardiothorac Surg; 2009 Nov; 4():65. PubMed ID: 19912629 [TBL] [Abstract][Full Text] [Related]
15. Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report. Cannas A; Solla P; Floris G; Borghero G; Tacconi P; Spissu A Clin Neuropharmacol; 2005; 28(5):252. PubMed ID: 16239770 [No Abstract] [Full Text] [Related]
16. Pergolide in Parkinson's disease: time for a change? Grosset KA; Grosset DG Lancet; 2004 Jun; 363(9424):1907-8. PubMed ID: 15183636 [No Abstract] [Full Text] [Related]
17. The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks? Heart Advis; 2009 Aug; 12(8):8. PubMed ID: 21188763 [No Abstract] [Full Text] [Related]
18. [Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations]. Corvol JC; Schüpbach M; Bonnet AM; Rev Neurol (Paris); 2005 Jul; 161(6-7):637-43. PubMed ID: 16141947 [TBL] [Abstract][Full Text] [Related]
19. Pergolide-induced pleuropulmonary fibrosis. Bleumink GS; van der Molen-Eijgenraam M; Strijbos JH; Sanwikarja S; van Puijenbroek EP; Stricker BH Clin Neuropharmacol; 2002; 25(5):290-3. PubMed ID: 12410064 [TBL] [Abstract][Full Text] [Related]